Leon Stankowski.jpg

Leon Stankowski, PhD

Scientific Director, Genetic and In Vitro Toxicology

Leon Stankowski, PhD, is responsible for guiding research and development for new service offerings and providing guidance on all aspects of toxicology to help clients reach their goal of regulatory approval for new products.

He is responsible for evaluating and addressing adverse toxicology issues when they arise, as well as designing specialized protocols and mechanistic studies to resolve them. He regularly reviews study results and adverse outcomes for compounds being developed by various pharmaceutical and other companies and has has contributed to multiple publications.

LinkedIn Profile